Finanzen von Rain Enhancement Technologies Holdco Inc (RAIN)RAINRain Enhancement Technologies Holdco Inc

Evaluating the bottom line, Rain Enhancement Technologies Holdco Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -47451.14%, while the net margin is -48637.00%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively RAIN converts its operational activities into shareholder value.

In the context of the broader market, RAIN competes directly with industry leaders such as PSQH and BIOT. With a market capitalization of $5.89M, it holds a significant position in the sector. When comparing efficiency, RAIN's gross margin of 100.00% stands against PSQH's 33.90% and BIOT's N/A. Such benchmarking helps identify whether Rain Enhancement Technologies Holdco Inc is trading at a premium or discount relative to its financial performance.

Rain Oncology has reported zero revenue for several quarters, with a net income loss of -$3,246,657 in Q2 2026. The gross margin for Q1 2026 was 100%, but this is not sustainable given the overall financial losses. The company has a current ratio of 0.03, indicating severe liquidity issues.